Background Although oral opioid agonist therapies (OATs), buprenorphine and methadone,
are effective first-line treatments, OAT remains largely underutilized due to low retention …

Background The average length of buprenorphine treatment for opioid use disorder is less
than 6 months. Objective We conducted a systematic review to determine what factors were …

Aims To examine patient and medication characteristics associated with retention and
continued illicit opioid use in methadone (MET) versus buprenorphine/naloxone (BUP) …

Background Retention in opioid substitution (OST) treatment is associated with substantial
reductions in all cause and overdose mortality. This systematic review aims to identify both …

Abstract Background and Aims There is limited evidence on the relationship between
retention in opioid agonist treatment for opioid dependence and characteristics of treatment …

Retention in medication-assisted treatment among opiate-dependent patients is associated
with better outcomes. This systematic review (55 articles, 2010–2014) found wide variability …

Abstract Background and Aims There is mounting evidence that opioid use disorder is
experienced differently by people of different genders and race/ethnicity groups. Similarly, in …

Introduction For opioid-dependent patients in the US and elsewhere, detoxification and
counseling-only aftercare are treatment mainstays. Long-term abstinence is rarely achieved; …

Abstract Background and Aims Ukraine's HIV epidemic remains concentrated among opioid‐
dependent people who inject drugs (PWID) where opioid agonist therapies (OAT) like …

Introduction Several pharmacotherapeutic interventions are available for maintenance
treatment for opioid-related disorders. However, previous meta-analyses have been limited …